CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Turn Therapeutics’ stock jumps on AD data and trial expansion

Data ReadoutpositivePositive
AI Analysis

Summary

Turn Therapeutics' stock rose on positive Alzheimer's disease data and announcement of trial expansion. The company announced trial progression for its AD program with favorable data.

Clinical Trial Data

Importance:6/10
Sentiment:
0.75
Alzheimer's Diseaseclinical trialstock movementtrial expansion
Related Companies

Read the original article

Published by yahoo_finance on July 8, 2026 11:17 AM

Read Original